ACS Publications. Most Trusted. Most Cited. Most Read
My Activity

Figure 1Loading Img

Pre-Steady-State Kinetic Characterization of Wild Type and 3‘-Azido-3‘-deoxythymidine (AZT) Resistant Human Immunodeficiency Virus Type 1 Reverse Transcriptase:  Implication of RNA Directed DNA Polymerization in the Mechanism of AZT Resistance

View Author Information
Department of Pharmacology, 333 Cedar Street, Yale University School of Medicine, New Haven, Connecticut 06520-8066
Cite this: Biochemistry 1997, 36, 46, 14064–14070
Publication Date (Web):November 18, 1997
Copyright © 1997 American Chemical Society

    Article Views





    Other access options


    There is lack of a correlation between biochemical studies and the observed clinical resistance of AIDS patients on long term AZT therapy. Mutant HIV-1 reverse transcriptase in the viral isolates from these patients shows a 100-fold decrease in sensitivity whereas little or no difference is observed in kinetic parameters in vitro using steady-state kinetic analysis. A detailed pre-steady-state kinetic analysis of wild type and the clinically important AZT resistant mutant (D67N, K70R, T215Y, K219Q) HIV-1 reverse transcriptase was conducted to understand the mechanistic basis of drug resistance. In contrast to steady-state techniques, a pre-steady-state kinetic analysis allows for the direct observation of catalytic events occurring at the active site of the enzyme, including subtle conformational changes enabling a greater degree of mechanistic detail. In this investigation the rate of incorporation of dTMP and AZTMP by wild type and mutant HIV-1 RT was determined using an RNA and the corresponding DNA template. The present study has shown a 1.5-fold decrease in the rate constant for polymerization (kpol) and a 2.5-fold decrease in the equilibrium dissociation constant (Kd) for AZTTP for the mutant reverse transcriptase as compared to the wild type, for RNA dependent DNA replication. These values translate into a 4-fold decrease in selectivity (kpol/Kd) for AZTMP incorporation by mutant reverse transcriptase as compared to wild type for RNA dependent DNA replication. No such decrease in selectivity was detected for DNA dependent replication. These results suggest that the basis of AZT resistance is related to RNA dependent replication rather than DNA dependent replication.

    Read this article

    To access this article, please review the available access options below.

    Get instant access

    Purchase Access

    Read this article for 48 hours. Check out below using your ACS ID or as a guest.


    Access through Your Institution

    You may have access to this article through your institution.

    Your institution does not have access to this content. You can change your affiliated institution below.

     This work was supported by NIH Grant GM49551 to K.S.A.

     Present address:  Massachusetts College of Pharmacy & Allied Health Sciences, 179 Longwood Ave., Boston, MA 02115.


     Author to whom correspondence should be addressed. Telephone:  (203)-785-4526. Fax:  (203)-785-7670. email:  karen.anderson@

     Abstract published in Advance ACS Abstracts, November 1, 1997.

    Cited By

    This article is cited by 78 publications.

    1. Thomas Lane, Vadim Makarov, Julie A. E. Nelson, Rick B. Meeker, Giuseppina Sanna, Olga Riabova, Elena Kazakova, Natalia Monakhova, Andrey Tsedilin, Fabio Urbina, Thane Jones, Ashley Suchy, Sean Ekins. N-Phenyl-1-(phenylsulfonyl)-1H-1,2,4-triazol-3-amine as a New Class of HIV-1 Non-nucleoside Reverse Transcriptase Inhibitor. Journal of Medicinal Chemistry 2023, 66 (9) , 6193-6217.
    2. Christopher R. Dilmore, Jeffrey J. DeStefano. HIV Reverse Transcriptase Pre-Steady-State Kinetic Analysis of Chain Terminators and Translocation Inhibitors Reveals Interactions between Magnesium and Nucleotide 3′-OH. ACS Omega 2021, 6 (22) , 14621-14628.
    3. Christopher M. Bailey, Todd J. Sullivan, Pinar Iyidogan, Julian Tirado-Rives, Raymond Chung, Juliana Ruiz-Caro, Ebrahim Mohamed, William Jorgensen, Roger Hunter, and Karen S. Anderson . Bifunctional Inhibition of Human Immunodeficiency Virus Type 1 Reverse Transcriptase: Mechanism and Proof-of-Concept as a Novel Therapeutic Design Strategy. Journal of Medicinal Chemistry 2013, 56 (10) , 3959-3968.
    4. Matthew W. Kellinger and Kenneth A. Johnson . Role of Induced Fit in Limiting Discrimination against AZT by HIV Reverse Transcriptase. Biochemistry 2011, 50 (22) , 5008-5015.
    5. Anthony J. Berdis. Mechanisms of DNA Polymerases. Chemical Reviews 2009, 109 (7) , 2862-2879.
    6. Mark Skasko, Tracy L. Diamond and Baek Kim. Mechanistic Variations among Reverse Transcriptases of Simian Immunodeficiency Virus Variants Isolated from African Green Monkeys. Biochemistry 2009, 48 (23) , 5389-5395.
    7. Anthony J. Berdis. DNA Polymerases as Therapeutic Targets. Biochemistry 2008, 47 (32) , 8253-8260.
    8. Theodore P. Ortiz,, Jason A. Marshall,, Lauren A. Meyer,, Ryan W. Davis,, Jed C. Macosko,, Jeremy Hatch,, David J. Keller, and, James A. Brozik. Stepping Statistics of Single HIV-1 Reverse Transcriptase Molecules during DNA Polymerization. The Journal of Physical Chemistry B 2005, 109 (33) , 16127-16131.
    9. Joseph A. Vaccaro,, Hansi A. Singh, and, Karen S. Anderson. Initiation of Minus-Strand DNA Synthesis by Human Immunodeficiency Virus Type 1 Reverse Transcriptase. Biochemistry 1999, 38 (48) , 15978-15985.
    10. Joseph A. Vaccaro and, Karen S. Anderson. Implication of the tRNA Initiation Step for Human Immunodeficiency Virus Type 1 Reverse Transcriptase in the Mechanism of 3‘-Azido-3‘-deoxythymidine (AZT) Resistance. Biochemistry 1998, 37 (40) , 14189-14194.
    11. Woo Suk Choi, Peng He, Arti Pothukuchy, Jimmy Gollihar, Andrew D. Ellington, Wei Yang. How a B family DNA polymerase has been evolved to copy RNA. Proceedings of the National Academy of Sciences 2020, 117 (35) , 21274-21280.
    12. Ankita Dutta, Mohit Mazumder, Mashkoor Alam, Samudrala Gourinath, Apurba Kumar Sau. Metal-induced change in catalytic loop positioning in Helicobacter pylori arginase alters catalytic function. Biochemical Journal 2019, 476 (23) , 3595-3614.
    13. Katherine L. Seley-Radtke, Mary K. Yates. The evolution of nucleoside analogue antivirals: A review for chemists and non-chemists. Part 1: Early structural modifications to the nucleoside scaffold. Antiviral Research 2018, 154 , 66-86.
    14. Omri Malik, Hadeel Khamis, Sergei Rudnizky, Ariel Kaplan. The mechano-chemistry of a monomeric reverse transcriptase. Nucleic Acids Research 2017, 45 (22) , 12954-12962.
    15. Omri Malik, Hadeel Khamis, Sergei Rudnizky, Ailie Marx, Ariel Kaplan. Pausing kinetics dominates strand-displacement polymerization by reverse transcriptase. Nucleic Acids Research 2017, 45 (17) , 10190-10205.
    16. An Li, Jessica L. Ziehr, Kenneth A. Johnson. A new general method for simultaneous fitting of temperature and concentration dependence of reaction rates yields kinetic and thermodynamic parameters for HIV reverse transcriptase specificity. Journal of Biological Chemistry 2017, 292 (16) , 6695-6702.
    17. Grant Schauer, Nicolas Sluis-Cremer. HIV-1 Resistance to Reverse Transcriptase Inhibitors. 2017, 523-542.
    18. Andrea C. Mislak, Karen S. Anderson. Insights into the Molecular Mechanism of Polymerization and Nucleoside Reverse Transcriptase Inhibitor Incorporation by Human PrimPol. Antimicrobial Agents and Chemotherapy 2016, 60 (1) , 561-569.
    19. Gina M. Lenzi, Robert A. Domaoal, Dong-Hyun Kim, Raymond F. Schinazi, Baek Kim. Mechanistic and Kinetic Differences between Reverse Transcriptases of Vpx Coding and Non-coding Lentiviruses. Journal of Biological Chemistry 2015, 290 (50) , 30078-30086.
    20. Paul L. Boyer, Kalyan Das, Eddy Arnold, Stephen H. Hughes. Analysis of the Zidovudine Resistance Mutations T215Y, M41L, and L210W in HIV-1 Reverse Transcriptase. Antimicrobial Agents and Chemotherapy 2015, 59 (12) , 7184-7196.
    21. Biplab Mondal, Somjit Hazra, Kishor Naktode, Tarun K. Panda, B. Roy. PhI(OAc)2 and BF3–OEt2 mediated heterocyclization: metal-free synthesis of pyrimidine-annulated oxazolines. Tetrahedron Letters 2014, 55 (41) , 5625-5628.
    22. Andrea C. Mislak, Kathleen M. Frey, Mariela Bollini, William L. Jorgensen, Karen S. Anderson. A mechanistic and structural investigation of modified derivatives of the diaryltriazine class of NNRTIs targeting HIV-1 reverse transcriptase. Biochimica et Biophysica Acta (BBA) - General Subjects 2014, 1840 (7) , 2203-2211.
    23. Grant Schauer, Nicolas Sluis-Cremer. HIV-1 Resistance to Reverse Transcriptase Inhibitors. 2014, 1-17.
    24. Zhinan Jin, Vincent Leveque, Han Ma, Kenneth A. Johnson, Klaus Klumpp. NTP-mediated nucleotide excision activity of hepatitis C virus RNA-dependent RNA polymerase. Proceedings of the National Academy of Sciences 2013, 110 (5)
    25. Gilda Tachedjian, Nicolas Sluis-Cremer. Role of RNase H Activity in NRTI/NNRTI Drug Resistance. 2013, 281-303.
    26. Jessica A. Brown, Lindsey R. Pack, Jason D. Fowler, Zucai Suo. Pre-Steady-State Kinetic Analysis of the Incorporation of Anti-HIV Nucleotide Analogs Catalyzed by Human X- and Y-Family DNA Polymerases. Antimicrobial Agents and Chemotherapy 2011, 55 (1) , 276-283.
    27. Xiongying Tu, Kalyan Das, Qianwei Han, Joseph D Bauman, Arthur D Clark, Xiaorong Hou, Yulia V Frenkel, Barbara L Gaffney, Roger A Jones, Paul L Boyer, Stephen H Hughes, Stefan G Sarafianos, Eddy Arnold. Structural basis of HIV-1 resistance to AZT by excision. Nature Structural & Molecular Biology 2010, 17 (10) , 1202-1209.
    28. Scott J. Garforth, Robert A. Domaoal, Chisanga Lwatula, Mark J. Landau, Amanda J. Meyer, Karen S. Anderson, Vinayaka R. Prasad. K65R and K65A Substitutions in HIV-1 Reverse Transcriptase Enhance Polymerase Fidelity by Decreasing Both dNTP Misinsertion and Mispaired Primer Extension Efficiencies. Journal of Molecular Biology 2010, 401 (1) , 33-44.
    29. Matthew W. Kellinger, Kenneth A. Johnson. Nucleotide-dependent conformational change governs specificity and analog discrimination by HIV reverse transcriptase. Proceedings of the National Academy of Sciences 2010, 107 (17) , 7734-7739.
    30. Kamalendra Singh, Bruno Marchand, Karen A. Kirby, Eleftherios Michailidis, Stefan G. Sarafianos. Structural Aspects of Drug Resistance and Inhibition of HIV-1 Reverse Transcriptase. Viruses 2010, 2 (2) , 606-638.
    31. Pamela L. Russ, Maria J. Gonzalez‐Moa, B. Christie Vu, Dina M. Sigano, James A. Kelley, Christopher C. Lai, Jeffrey R. Deschamps, Stephen H. Hughes, Victor E. Marquez. North‐ and South‐Bicyclo[3.1.0]Hexene Nucleosides: The Effect of Ring Planarity on Anti‐HIV Activity. ChemMedChem 2009, 4 (8) , 1354-1363.
    32. Stefan G. Sarafianos, Bruno Marchand, Kalyan Das, Daniel M. Himmel, Michael A. Parniak, Stephen H. Hughes, Eddy Arnold. Structure and Function of HIV-1 Reverse Transcriptase: Molecular Mechanisms of Polymerization and Inhibition. Journal of Molecular Biology 2009, 385 (3) , 693-713.
    33. Bruno Marchand, Stefan G. Sarafianos. HIV-1 Reverse Transcriptase Inhibitors and Mechanisms of Resistance. 2009, 549-570.
    34. Luis Menéndez-Arias. Mechanisms of resistance to nucleoside analogue inhibitors of HIV-1 reverse transcriptase. Virus Research 2008, 134 (1-2) , 124-146.
    35. Guangwei Yang, Jimin Wang, Yao Cheng, Ginger E. Dutschman, Hiromichi Tanaka, Masanori Baba, Yung-Chi Cheng. Mechanism of Inhibition of Human Immunodeficiency Virus Type 1 Reverse Transcriptase by a Stavudine Analogue, 4′-Ethynyl Stavudine Triphosphate. Antimicrobial Agents and Chemotherapy 2008, 52 (6) , 2035-2042.
    36. Robert A. Domaoal, Moira McMahon, Chloe L. Thio, Christopher M. Bailey, Julian Tirado-Rives, Aleksander Obikhod, Mervi Detorio, Kimberly L. Rapp, Robert F. Siliciano, Raymond F. Schinazi, Karen S. Anderson. Pre-steady-state Kinetic Studies Establish Entecavir 5′-Triphosphate as a Substrate for HIV-1 Reverse Transcriptase. Journal of Biological Chemistry 2008, 283 (9) , 5452-5459.
    37. Tatiana Ilina, Michael A. Parniak. Inhibitors of HIV‐1 Reverse Transcriptase. 2008, 121-167.
    38. Aravind Basavapathruni, Karen S. Anderson. Reverse transcription of the HIV‐1 pandemic. The FASEB Journal 2007, 21 (14) , 3795-3808.
    39. Harold R. Lee, Kenneth A. Johnson. Fidelity and Processivity of Reverse Transcription by the Human Mitochondrial DNA Polymerase. Journal of Biological Chemistry 2007, 282 (44) , 31982-31989.
    40. Bruno Marchand, Kirsten L. White, John K. Ly, Nicolas A. Margot, Ruth Wang, Martin McDermott, Michael D. Miller, Matthias Götte. Effects of the Translocation Status of Human Immunodeficiency Virus Type 1 Reverse Transcriptase on the Efficiency of Excision of Tenofovir. Antimicrobial Agents and Chemotherapy 2007, 51 (8) , 2911-2919.
    41. Nicolas Sluis-Cremer. Molecular Mechanisms of HIV-1 Resistance to Nucleoside and Nucleotide Reverse Transcriptase Inhibitors. Future HIV Therapy 2007, 1 (2) , 191-201.
    42. Eisuke Murakami, Haiying Bao, Aravind Basavapathruni, Christopher M Bailey, Jinfa Du, Holly M Micolochick Steuer, Congrong Niu, Tony Whitaker, Karen S Anderson, Michael J Otto, Phillip A Furman. Mechanism of Action of (-)-(2 R ,4 R )-1-(2-hydroxymethyl-1,3-dioxolan-4-yl)thymine as an anti-HIV agent. Antiviral Chemistry and Chemotherapy 2007, 18 (2) , 83-92.
    43. Guangwei Yang, Ginger E. Dutschman, Chuan-Jen Wang, Hiromichi Tanaka, Masanori Baba, Karen S. Anderson, Yung-Chi Cheng. Highly selective action of triphosphate metabolite of 4′-ethynyl D4T: A novel anti-HIV compound against HIV-1 RT. Antiviral Research 2007, 73 (3) , 185-191.
    44. Joy Y. Feng, Florence T. Myrick, Nicolas A. Margot, Gilbert B. Mulamba, Laurence Rimsky, Katyna Borroto-Esoda, Boulbaba Selmi, Bruno Canard. Virologic and Enzymatic Studies Revealing the Mechanism of K65R- and Q151M-Associated HIV-1 Drug Resistance Towards Emtricitabine and Lamivudine. Nucleosides, Nucleotides and Nucleic Acids 2006, 25 (1) , 89-107.
    45. Nicolas Sluis-Cremer, Dominique Arion, Urvi Parikh, Dianna Koontz, Raymond F. Schinazi, John W. Mellors, Michael A. Parniak. The 3′-Azido Group Is Not the Primary Determinant of 3′-Azido-3′-deoxythymidine (AZT) Responsible for the Excision Phenotype of AZT-resistant HIV-1. Journal of Biological Chemistry 2005, 280 (32) , 29047-29052.
    46. Mark Skasko, Kellie K. Weiss, Holly M. Reynolds, Varuni Jamburuthugoda, Kwi Lee, Baek Kim. Mechanistic Differences in RNA-dependent DNA Polymerization and Fidelity between Murine Leukemia Virus and HIV-1 Reverse Transcriptases. Journal of Biological Chemistry 2005, 280 (13) , 12190-12200.
    47. Joy Y. Feng, Eisuke Murakami, Suzana M. Zorca, Allison A. Johnson, Kenneth A. Johnson, Raymond F. Schinazi, Phillip A. Furman, Karen S. Anderson. Relationship between Antiviral Activity and Host Toxicity: Comparison of the Incorporation Efficiencies of 2′,3′-Dideoxy-5-Fluoro-3′-Thiacytidine-Triphosphate Analogs by Human Immunodeficiency Virus Type 1 Reverse Transcriptase and Human Mitochondrial DNA Polymerase. Antimicrobial Agents and Chemotherapy 2004, 48 (4) , 1300-1306.
    48. Aravind Basavapathruni, Christopher M. Bailey, Karen S. Anderson. Defining a Molecular Mechanism of Synergy between Nucleoside and Nonnucleoside AIDS Drugs. Journal of Biological Chemistry 2004, 279 (8) , 6221-6224.
    49. Gregory L. Verdine, Derek P.G. Norman. Covalent Trapping of Protein-DNA Complexes. Annual Review of Biochemistry 2003, 72 (1) , 337-366.
    50. Peter R. Meyer, Suzanne E. Matsuura, Dianna Zonarich, Rahul R. Chopra, Eric Pendarvis, Holly Z. Bazmi, John W. Mellors, Walter A. Scott. Relationship between 3′-Azido-3′-Deoxythymidine Resistance and Primer Unblocking Activity in Foscarnet-Resistant Mutants of Human Immunodeficiency Virus Type 1 Reverse Transcriptase. Journal of Virology 2003, 77 (11) , 6127-6137.
    51. Susan E. Lim, Mikhail V. Ponamarev, Matthew J. Longley, William C. Copeland. Structural Determinants in Human DNA Polymerase γ Account for Mitochondrial Toxicity from Nucleoside Analogs. Journal of Molecular Biology 2003, 329 (1) , 45-57.
    52. Adrian S. Ray, Aravind Basavapathruni, Karen S. Anderson. Mechanistic Studies to Understand the Progressive Development of Resistance in Human Immunodeficiency Virus Type 1 Reverse Transcriptase to Abacavir. Journal of Biological Chemistry 2002, 277 (43) , 40479-40490.
    53. Lisa K. Naeger, Nicolas A. Margot, Michael D. Miller. ATP-Dependent Removal of Nucleoside Reverse Transcriptase Inhibitors by Human Immunodeficiency Virus Type 1 Reverse Transcriptase. Antimicrobial Agents and Chemotherapy 2002, 46 (7) , 2179-2184.
    54. Mickaël Rigourd, Chantal Ehresmann, Michael A. Parniak, Bernard Ehresmann, Roland Marquet. Primer Unblocking and Rescue of DNA Synthesis by Azidothymidine (AZT)-resistant HIV-1 Reverse Transcriptase. Journal of Biological Chemistry 2002, 277 (21) , 18611-18618.
    55. Youhoon Chong, Katyna Borroto-Esoda, Phillip A Furman, Raymond F Schinazi, Chung K Chu. Molecular Mechanism of DAPD/DXG against Zidovudine- and Lamivudine- Drug Resistant Mutants: A Molecular Modelling Approach. Antiviral Chemistry and Chemotherapy 2002, 13 (2) , 115-128.
    56. Shoukat H Qari, Mark Winters, Anne-Mieke Vandamme, Thomas Merigan, Walid Heneine. A Rapid Phenotypic Assay for Detecting Multiple Nucleoside Analogue Reverse Transcriptase Inhibitor-Resistant HIV-1 in Plasma. Antiviral Therapy 2002, 7 (2) , 131-139.
    57. Karen S. Anderson. Reverse Transcriptases. 2002
    58. Catherine Isel, Chantal Ehresmann, Philippe Walter, Bernard Ehresmann, Roland Marquet. The Emergence of Different Resistance Mechanisms toward Nucleoside Inhibitors Is Explained by the Properties of the Wild Type HIV-1 Reverse Transcriptase. Journal of Biological Chemistry 2001, 276 (52) , 48725-48732.
    59. Allison A. Johnson, Adrian S. Ray, Jeremiah Hanes, Zucai Suo, Joseph M. Colacino, Karen S. Anderson, Kenneth A. Johnson. Toxicity of Antiviral Nucleoside Analogs and the Human Mitochondrial DNA Polymerase. Journal of Biological Chemistry 2001, 276 (44) , 40847-40857.
    60. Inna I. Gorshkova, Jason W. Rausch, Stuart F.J. Le Grice, Robert J. Crouch. HIV-1 Reverse Transcriptase Interaction with Model RNA–DNA Duplexes. Analytical Biochemistry 2001, 291 (2) , 198-206.
    61. Jesús F. Cabodevilla, Leticia Odriozola, Esteban Santiago, Juan J. Martínez‐Irujo. Factors affecting the dimerization of the p66 form of HIV‐1 reverse transcriptase. European Journal of Biochemistry 2001, 268 (5) , 1163-1172.
    62. Phillip A. Furman, Jerry Jeffrey, Laura L. Kiefer, Joy Y. Feng, Karen S. Anderson, Katyna Borroto-Esoda, Edgar Hill, William C. Copeland, Chung K. Chu, Jean-Pierre Sommadossi, Irina Liberman, Raymond F. Schinazi, George R. Painter. Mechanism of Action of 1-β- d -2,6-Diaminopurine Dioxolane, a Prodrug of the Human Immunodeficiency Virus Type 1 Inhibitor 1-β- d -Dioxolane Guanosine. Antimicrobial Agents and Chemotherapy 2001, 45 (1) , 158-165.
    63. Mickaël Rigourd, Jean-Marc Lanchy, Stuart F.J. Le Grice, Bernard Ehresmann, Chantal Ehresmann, Roland Marquet. Inhibition of the Initiation of HIV-1 Reverse Transcription by 3′-Azido-3′-deoxythymidine. Journal of Biological Chemistry 2000, 275 (35) , 26944-26951.
    64. Jean-Bernard Lazaro, Joëlle Boretto, Boulbaba Selmi, Jean-Paul Capony, Bruno Canard. Phosphorylation of AZT-Resistant Human Immunodeficiency Virus Type 1 Reverse Transcriptase by Casein Kinase II in Vitro: Effects on Inhibitor Sensitivity. Biochemical and Biophysical Research Communications 2000, 275 (1) , 26-32.
    65. Thomas A. Kunkel, Katarzyna Bebenek. DNA Replication Fidelity. Annual Review of Biochemistry 2000, 69 (1) , 497-529.
    66. Matthias Götte, Dominique Arion, Michael A. Parniak, Mark A. Wainberg. The M184V Mutation in the Reverse Transcriptase of Human Immunodeficiency Virus Type 1 Impairs Rescue of Chain-Terminated DNA Synthesis. Journal of Virology 2000, 74 (8) , 3579-3585.
    67. Jamie J. Arnold, Craig E. Cameron. Poliovirus RNA-dependent RNA Polymerase (3Dpol). Journal of Biological Chemistry 2000, 275 (8) , 5329-5336.
    68. Joseph A. Vaccaro, K. Mark Parnell, Stephanie A. Terezakis, Karen S. Anderson. Mechanism of Inhibition of the Human Immunodeficiency Virus Type 1 Reverse Transcriptase by d4TTP: an Equivalent Incorporation Efficiency Relative to the Natural Substrate dTTP. Antimicrobial Agents and Chemotherapy 2000, 44 (1) , 217-221.
    69. Bruno Canard, Kajal Chowdhury, Robert Sarfati, Sylvie Doublié, Charles C. Richardson. The Motif D Loop of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Is Critical for Nucleoside 5′-Triphosphate Selectivity. Journal of Biological Chemistry 1999, 274 (50) , 35768-35776.
    70. Xiaoling Li, William K Chan. Transport, metabolism and elimination mechanisms of anti-HIV agents. Advanced Drug Delivery Reviews 1999, 39 (1-3) , 81-103.
    71. Joy Y. Feng, Junxing Shi, Raymond F. Schinazi, Karen S. Anderson. Mechanistic studies show that (−)‐FTC‐TP is a better inhibitor of HIV‐1 reverse transcriptase than 3TC‐TP. The FASEB Journal 1999, 13 (12) , 1511-1517.
    72. Peter R Meyer, Suzanne E Matsuura, A.Mohsin Mian, Antero G So, Walter A Scott. A Mechanism of AZT Resistance. Molecular Cell 1999, 4 (1) , 35-43.
    73. Dominique Arion, Michael A. Parniak. HIV resistance to zidovudine: the role of pyrophosphorolysis. Drug Resistance Updates 1999, 2 (2) , 91-95.
    74. Peter R. Meyer, Suzanne E. Matsuura, Antero G. So, Walter A. Scott. Unblocking of chain-terminated primer by HIV-1 reverse transcriptase through a nucleotide-dependent mechanism. Proceedings of the National Academy of Sciences 1998, 95 (23) , 13471-13476.
    75. Olga D. Zakharova, Olga A. Suturina, Olga A. Timofeeva, Severin O. Gudima, Vitaly I. Yamkovoi, Sergei N. Kochetkov, Michel Fournier, Laura Tarrago-Litvak, Simon Litvak, Georgy A. Nevinsky. Interaction of tRNA-Derivatives and Oligonucleotide Primers with AZT-Resistant Mutants of HIV-1 Reverse Transcriptase. Bioorganic & Medicinal Chemistry 1998, 6 (11) , 2041-2049.
    76. Bruno Canard, Simon R. Sarfati, Charles C. Richardson. Enhanced Binding of Azidothymidine-resistant Human Immunodeficiency Virus 1 Reverse Transcriptase to the 3′-Azido-3′-deoxythymidine 5′-Monophosphate-terminated Primer. Journal of Biological Chemistry 1998, 273 (23) , 14596-14604.
    77. Nancy Shulman, Mark Winters. Resistance to Nucleoside and Nucleotide Reverse Transcriptase Inhibitors. , 179-207.
    78. . RNA-directed DNA polymerase. , 492-508.

    Pair your accounts.

    Export articles to Mendeley

    Get article recommendations from ACS based on references in your Mendeley library.

    Pair your accounts.

    Export articles to Mendeley

    Get article recommendations from ACS based on references in your Mendeley library.

    You’ve supercharged your research process with ACS and Mendeley!

    STEP 1:
    Click to create an ACS ID

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Your Mendeley pairing has expired. Please reconnect